Evolving concepts of rheumatoid arthritis
暂无分享,去创建一个
[1] E. Kodama,et al. Antibodies to 65Kd heat-shock protein were elevated in rheumatoid arthritis , 1994, Clinical Rheumatology.
[2] D. Chang,et al. Microsatallite Instability and Suppressed DNA Repair Enzyme Expression in Rheumatoid Arthritis , 2003, The Journal of Immunology.
[3] P. Schur,et al. Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. , 2003, Arthritis and rheumatism.
[4] L. Joosten,et al. IL-17 Promotes Bone Erosion in Murine Collagen-Induced Arthritis Through Loss of the Receptor Activator of NF-κB Ligand/Osteoprotegerin Balance 1 , 2003, The Journal of Immunology.
[5] E. Wagner,et al. HIF-1 mediated upregulation of VEGF and VEGF-R in systemic sclerosis (SSc): Imbalance with angiostatic factors suggests VEGF as a novel option for the treatment of ischemia in patients with SSc , 2002, Annals of the rheumatic diseases.
[6] Andrea Vondracek,et al. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis. , 2002, Arthritis and rheumatism.
[7] C. Benoist,et al. Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis , 2002, Science.
[8] R. Fanin,et al. Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells. , 2002, Arthritis and rheumatism.
[9] A. Wunder,et al. Synovial mast cells require C5a receptor (CD88) for arthritis induction , 2003, Arthritis Research & Therapy.
[10] D. Green,et al. Regional analysis of p53 mutations in rheumatoid arthritis synovium , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[11] W. Maśliński,et al. High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment. , 2002, Arthritis and rheumatism.
[12] G. Steiner,et al. Identification of citrullinated rheumatoid arthritis-specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay. , 2002, Arthritis and rheumatism.
[13] J. Smolen,et al. Autoantibodies in rheumatoid arthritis and their clinical significance , 2002, Arthritis research.
[14] S. Barnum,et al. Local production of complement proteins in rheumatoid arthritis synovium. , 2002, Arthritis and rheumatism.
[15] M. Karin,et al. Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis. , 2002, Arthritis and rheumatism.
[16] G. Firestein,et al. How important are T cells in chronic rheumatoid synovitis?: II. T cell-independent mechanisms from beginning to end. , 2002, Arthritis and rheumatism.
[17] Ralph Weissleder,et al. Arthritis critically dependent on innate immune system players. , 2002, Immunity.
[18] G. Firestein,et al. Immunostimulatory DNA Sequences Influence the Course of Adjuvant Arthritis1 , 2002, The Journal of Immunology.
[19] Takafumi Yoshida,et al. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. , 2001, The Journal of clinical investigation.
[20] A R Pettit,et al. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. , 2001, The American journal of pathology.
[21] J. Gebe,et al. T Cell Selection and Differential Activation on Structurally Related HLA-DR4 Ligands1 , 2001, The Journal of Immunology.
[22] P. Tak,et al. Inhibitor of nuclear factor κB kinase β is a key regulator of synovial inflammation , 2001 .
[23] V. Dixit,et al. TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice , 2001, Nature Immunology.
[24] M. Karin,et al. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. , 2001, The Journal of clinical investigation.
[25] M. Chamorro,et al. Blockade of Wnt-5A/frizzled 5 signaling inhibits rheumatoid synoviocyte activation. , 2001, Arthritis and rheumatism.
[26] G. Firestein,et al. Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion. , 2001, Arthritis and rheumatism.
[27] A. Manning,et al. NF-κB Regulation by IκB Kinase-2 in Rheumatoid Arthritis Synoviocytes1 , 2001, The Journal of Immunology.
[28] M. Feldmann,et al. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? , 2001, Annual review of immunology.
[29] R N Maini,et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. , 2000, The New England journal of medicine.
[30] Qingbo Xu,et al. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. , 2000, Arthritis and rheumatism.
[31] F. Breedveld,et al. HLA association with autoimmune disease: a failure to protect? , 2000, Rheumatology.
[32] L. Joosten,et al. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. , 2000, The Journal of clinical investigation.
[33] F. Breedveld,et al. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. , 2000, Arthritis and rheumatism.
[34] A. Poole,et al. Isolation and characteristics of autoreactive T cells specific to aggrecan G1 domain from rheumatoid arthritis patients , 2000, Cell Research.
[35] T. Tahira,et al. Analysis of p53 tumour suppressor gene somatic mutations in rheumatoid arthritis synovium. , 2000, Rheumatology.
[36] I. McInnes,et al. A proinflammatory role for IL-18 in rheumatoid arthritis. , 1999, The Journal of clinical investigation.
[37] F. Breedveld,et al. Analysis of serial synovial biopsies in patients with rheumatoid arthritis: description of a control group without clinical improvement after treatment with interleukin 10 or placebo. , 1999, The Journal of rheumatology.
[38] Josef M. Penninger,et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand , 1999, Nature.
[39] A. Baldwin,et al. NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[40] T. Sumida,et al. Monoclonal expansion of synoviocytes in rheumatoid arthritis. , 1998, Arthritis and rheumatism.
[41] R. Pierce,et al. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines. , 1998, Arthritis and rheumatism.
[42] F. Breedveld,et al. Poor expression of T cell-derived cytokines and activation and proliferation markers in early rheumatoid synovial tissue. , 1998, Clinical immunology and immunopathology.
[43] P. Miossec,et al. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. , 1998, Journal of immunology.
[44] S. Gay,et al. Clonally-related Immunoglobulin VH Domains and Nonrandom Use of DH Gene Segments in Rheumatoid Arthritis Synovium , 1998, Molecular medicine.
[45] F. Medina,et al. Paleopathology in osseous remains from the 16th century. A survey of rheumatic diseases. , 1998, The Journal of rheumatology.
[46] D. A. Walsh,et al. Focally regulated endothelial proliferation and cell death in human synovium. , 1998, The American journal of pathology.
[47] C. Mackay,et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.
[48] T. Rème,et al. Mutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue , 1998, Clinical and experimental immunology.
[49] A. Manning,et al. AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis. , 1998, Autoimmunity.
[50] D. Green,et al. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[51] E. Tindall,et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. , 1997, The New England journal of medicine.
[52] A. Boots,et al. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. , 1997, Arthritis and rheumatism.
[53] D. Fox,et al. The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives. , 1997, Arthritis and rheumatism.
[54] K. Tanaka,et al. Studies on the contribution of c-fos/AP-1 to arthritic joint destruction. , 1997, Journal of Clinical Investigation.
[55] G. Firestein. Somatic mutation in the tumore suppressor gene in erosive rheumatoid arthritis synovium , 1997 .
[56] D E Griswold,et al. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. , 1996, The Journal of pharmacology and experimental therapeutics.
[57] V. Kouskoff,et al. Organ-Specific Disease Provoked by Systemic Autoimmunity , 1996, Cell.
[58] D. Kirschmann,et al. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles. , 1995, Journal of immunology.
[59] J. Goronzy,et al. HLA-DRB1 molecules and antigenic experience shape the repertoire of CD4 T cells. , 1995, Human immunology.
[60] J. Seyer,et al. Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen. , 1995, Autoimmunity.
[61] F. Emmrich,et al. Synovial fibroblast-like cells strongly express jun-B and C-fos proto-oncogenes in rheumatoid- and osteoarthritis. , 1995, Scandinavian journal of rheumatology. Supplement.
[62] J. Woody,et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis , 1994, The Lancet.
[63] M. Feldmann,et al. Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[64] Don C. Wiley,et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.
[65] C. Weyand,et al. The Influence of HLA-DRB1 Genes on Disease Severity in Rheumatoid Arthritis , 1992, Annals of Internal Medicine.
[66] G. Firestein,et al. How important are T cells in chronic rheumatoid synovitis? , 1990, Arthritis and rheumatism.
[67] R. Maki,et al. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. , 1990, Journal of immunology.
[68] M. Feldmann,et al. INHIBITORY EFFECT OF TNFα ANTIBODIES ON SYNOVIAL CELL INTERLEUKIN-1 PRODUCTION IN RHEUMATOID ARTHRITIS , 1989, The Lancet.
[69] J. Roudier,et al. Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[70] D. Stage,et al. HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. , 1989, Arthritis and rheumatism.
[71] B. Rothschild,et al. Symmetrical erosive peripheral polyarthritis in the Late Archaic Period of Alabama. , 1988, Science.
[72] M. Rowley,et al. Collagen antibodies in rheumatoid arthritis. Significance of antibodies to denatured collagen and their association with HLA-DR4. , 1986, Arthritis and rheumatism.
[73] M. Dallman,et al. Immunisation against heterologous type II collagen induces arthritis in mice , 1980, Nature.
[74] P. Stastny. Mixed lymphocyte cultures in rheumatoid arthritis. , 1976, The Journal of clinical investigation.
[75] S. Ruddy,et al. ACTIVATION OF THE COMPLEMENT AND PROPERDIN SYSTEMS IN RHEUMATOID ARTHRITIS * , 1975, Annals of the New York Academy of Sciences.
[76] N. Zvaifler,et al. The immunopathology of joint inflammation in rheumatoid arthritis. , 1973, Advances in immunology.
[77] H. Holman,et al. AN UNUSUAL PROTEIN COMPONENT OF HIGH MOLECULAR WEIGHT IN THE SERUM OF CERTAIN PATIENTS WITH RHEUMATOID ARTHRITIS , 1957, The Journal of experimental medicine.